Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $2.1 million.

  • RxSight's Amortizatization of Intangibles fell 2262.72% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 1749.94%. This contributed to the annual value of $9.0 million for FY2024, which is 4663.51% up from last year.
  • Per RxSight's latest filing, its Amortizatization of Intangibles stood at $2.1 million for Q3 2025, which was down 2262.72% from $2.1 million recorded in Q2 2025.
  • RxSight's 5-year Amortizatization of Intangibles high stood at $2.8 million for Q3 2024, and its period low was $4000.0 during Q3 2021.
  • Over the past 5 years, RxSight's median Amortizatization of Intangibles value was $1.5 million (recorded in 2024), while the average stood at $1.2 million.
  • Per our database at Business Quant, RxSight's Amortizatization of Intangibles plummeted by 8620.69% in 2021 and then soared by 967500.0% in 2022.
  • Over the past 5 years, RxSight's Amortizatization of Intangibles (Quarter) stood at $11000.0 in 2021, then surged by 7018.18% to $783000.0 in 2022, then soared by 101.4% to $1.6 million in 2023, then surged by 66.65% to $2.6 million in 2024, then fell by 18.42% to $2.1 million in 2025.
  • Its Amortizatization of Intangibles stands at $2.1 million for Q3 2025, versus $2.1 million for Q2 2025 and $2.4 million for Q1 2025.